Abstract
Encephalitis is caused by inflammation and/or infection of the brain. It is a important condition in Asian children in whom it is most frequently caused by Japanese encephalitis virus, associated with a considerable burden of disease. Other common causes in Asia include: enteroviruses (especially enterovirus 71), dengue, influenza, the herpesviruses, measles, mumps and rubella viruses. Rabies continues to result in high mortality mostly in Asian children, which represents missed opportunities for prevention. Asia has also seen a number of emerging viral encephalitides including: Nipah, chikungunya, Chandipura and Me Tri viruses. We review the aetiology, epidemiology and outcome of encephalitis in Asian children and identify priorities for public health practice and research.
Keywords: Asia, aetiology, children, encephalitis, outcome.
Infectious Disorders - Drug Targets
Title:The Causes and Consequences of Childhood Encephalitis in Asia
Volume: 14 Issue: 2
Author(s): Philip N. Britton, Gulam Khandaker, Robert Booy and Cheryl A. Jones
Affiliation:
Keywords: Asia, aetiology, children, encephalitis, outcome.
Abstract: Encephalitis is caused by inflammation and/or infection of the brain. It is a important condition in Asian children in whom it is most frequently caused by Japanese encephalitis virus, associated with a considerable burden of disease. Other common causes in Asia include: enteroviruses (especially enterovirus 71), dengue, influenza, the herpesviruses, measles, mumps and rubella viruses. Rabies continues to result in high mortality mostly in Asian children, which represents missed opportunities for prevention. Asia has also seen a number of emerging viral encephalitides including: Nipah, chikungunya, Chandipura and Me Tri viruses. We review the aetiology, epidemiology and outcome of encephalitis in Asian children and identify priorities for public health practice and research.
Export Options
About this article
Cite this article as:
Britton N. Philip, Khandaker Gulam, Booy Robert and Jones A. Cheryl, The Causes and Consequences of Childhood Encephalitis in Asia, Infectious Disorders - Drug Targets 2014; 14 (2) . https://dx.doi.org/10.2174/1871526514666141021113317
DOI https://dx.doi.org/10.2174/1871526514666141021113317 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Understanding Helicases as a Means of Virus Control
Current Pharmaceutical Design Tetraspanins - Gateways for Infection
Infectious Disorders - Drug Targets Transition-State-Guided Drug Design for Treatment of Parasitic Neglected Tropical Diseases
Current Medicinal Chemistry Protein Conformational Diseases: From Mechanisms to Drug Designs
Current Drug Discovery Technologies Alphaviruses and their Derived Vectors as Anti-Tumor Agents
Current Cancer Drug Targets Playing with Fire: Manipulation of Macrophage Proinflammatory Signal Transduction by the Intracellular Protozoan Toxoplasma gondii
Current Immunology Reviews (Discontinued) Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design Gene Therapy to Improve Pancreatic Islet Transplantation for Type 1 Diabetes Mellitus
Current Diabetes Reviews Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
Letters in Drug Design & Discovery Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer’s Disease
Recent Patents on Anti-Infective Drug Discovery Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms
Current Genomics General Anesthetics in Brain Injury: Friends or Foes?
Current Pharmaceutical Design Therapeutic Agents for COVID-19: an Overview
Current Drug Therapy Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Borna Disease Virus (BDV): Neuropharmacological Effects of a CNS Viral Infection
Current Neuropharmacology Baseline Levels of Interleukine-6, Tumor-Necrosis Factor-Alpha and C-Reactive Protein in Treatment Naive Human Immunodeficiency Virus Infected Patients-A Study from a Tertiary-Care Hospital in Eastern India
Current Biomarkers (Discontinued) Metal and Inflammatory Targets for Alzheimers Disease
Current Drug Targets Levamisole-Induced Leukoencephalopathy in Russia: Analysis of 30 Cases
Current Drug Safety